J Neurol Surg A Cent Eur Neurosurg 2014; 75(02): 091-097
DOI: 10.1055/s-0033-1345688
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Repeated Transsphenoidal Surgery or Gamma Knife Radiosurgery in Recurrent Cushing Disease After Transsphenoidal Surgery

Mohammad Bodaghabadi
1   Department of Neuroradiosurgery, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
,
Hooman Riazi
2   Department of Neurosurgery, Tehran University of Medical Sciences, Imam Khomeini Hospital, Tehran, Islamic Republic of Iran
,
Shima Aran
3   Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States
,
Mohammad Ali Bitaraf
1   Department of Neuroradiosurgery, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
4   Department of Neuroradiosurgery, Iran Gamma Knife Center, Tehran, Islamic Republic of Iran
,
Mazdak Alikhani
4   Department of Neuroradiosurgery, Iran Gamma Knife Center, Tehran, Islamic Republic of Iran
,
Mahmud Alahverdi
5   Department of Medical Physics and Biomedical Engineering, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
,
Masoumeh Mohamadi
6   Department of Neuroradiosurgery, Tehran University of Medical Sciences, Imam Khomeini Hospital, Tehran, Islamic Republic of Iran
,
Keivan Shalileh
7   Department of Radiology, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
,
Maziar Azar
4   Department of Neuroradiosurgery, Iran Gamma Knife Center, Tehran, Islamic Republic of Iran
› Author Affiliations
Further Information

Publication History

02 August 2012

13 February 2013

Publication Date:
21 August 2013 (online)

Preview

Abstract

Background This study compared Gamma knife radiosurgery (GKRS) and repeated transsphenoidal adenomectomy (TSA) to find the best approach for recurrence of Cushing disease (CD) after unsuccessful first TSA.

Material and Methods Fifty-two patients with relapse of CD after TSA were enrolled and randomly underwent a second surgery or GKRS as the next therapeutic approach. They were followed for a mean period of 3.05 ± 0.8 years by physical examination and hormone measurement as well as magnetic resonance imaging.

Results No significant difference was observed in sex ratio, mean age, adenoma type, follow-up duration, and initial hormone level between the two groups. No significant relationship was found between preoperative 24-hour free urine cortisol and disease-free months or tumor volume among both groups. Our statistical analysis showed higher recurrence-free interval in the GKRS group compared with TSA group.

Conclusion With longer recurrence-free interval, GKRS could be considered a good treatment alternative to repeated TSA in recurrent CD.